ACSL4 and bladder transitional cell carcinoma: The results showed that ACSL4 expression was significantly higher in tumor in situ (TIS) and non-muscle-invasive BLCA (NMIBC) compared with muscle-invasive BLCA (MIBC), which suggested that ACSL4 may play a role in preventing BLCA invasion by facilitating immune cell infiltration (Figure 2B).